UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated

International journal of molecular sciences, 2021-03, Vol.22 (6), p.2979

Kanda, Naoko

2021

Volltextzugriff (PDF)

Editorial: Special Issue, "Molecular Advances in Skin Diseases 2.0"

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5928

Kanda, Naoko

2024

Volltextzugriff (PDF)

Editorial: Special Issue, “Molecular Advances in Skin Diseases”

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12396

Kanda, Naoko

2022

Volltextzugriff (PDF)

Nutrition and Psoriasis

International journal of molecular sciences, 2020-07, Vol.21 (15), p.5405

2020

Volltextzugriff (PDF)

The Roles of Sex Hormones in the Course of Atopic Dermatitis

International journal of molecular sciences, 2019-09, Vol.20 (19), p.4660

2019

Volltextzugriff (PDF)

Nutrition and Atopic Dermatitis

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2021-06, Vol.88 (3), p.171-177

2021

Volltextzugriff (PDF)

The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan

Journal of dermatology, 2022-11, Vol.49 (11), p.1158-1167

2022

Volltextzugriff (PDF)

Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan

Journal of dermatology, 2023-07, Vol.50 (7), p.869-879

2023

Volltextzugriff (PDF)

Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11968

2022

Volltextzugriff (PDF)

Atopic Dermatitis-Like Rash During Evolocumab Treatment of Familial Hypercholesterolemia

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2019-06, Vol.86 (3), p.187-190

2019

Volltextzugriff (PDF)

The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2212095-2212095

2023

Volltextzugriff (PDF)

Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2344591

2024

Volltextzugriff (PDF)

Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2307489-2307489

2024

Volltextzugriff (PDF)

Regulatory roles of sex hormones in cutaneous biology and immunology

Journal of dermatological science, 2005-04, Vol.38 (1), p.1-7

2005

Volltextzugriff (PDF)

Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis

International journal of molecular sciences, 2023-09, Vol.24 (18), p.14197

2023

Volltextzugriff (PDF)

Case of alopecia areata during dupilumab treatment for atopic dermatitis

Journal of dermatology, 2019-09, Vol.46 (9), p.e332-e333

2019

Volltextzugriff (PDF)

Change in Antinuclear Antibody Titers during Biologic Treatment for Psoriasis

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2023-02, Vol.90 (1), p.96-102, Article JNMS.2023_90-115

2023

Volltextzugriff (PDF)

A Case of Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome during Treatment with Brodalumab for Generalized Pustular Psoriasis

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2021, Vol.88 (6), p.569-573, Article JNMS.2021_88-517

2021

Volltextzugriff (PDF)

Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks

Frontiers in immunology, 2024-04, Vol.15, p.1365544

2024

Volltextzugriff (PDF)

Real‐world blood examination screening data before initiation of biologics for psoriasis patients

Journal of dermatology, 2022-05, Vol.49 (5), p.534-538

2022

Volltextzugriff (PDF)

Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2310643-2310643

2024

Volltextzugriff (PDF)

Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2291317-2291317

2024

Volltextzugriff (PDF)

Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2276043-2276043

2023

Volltextzugriff (PDF)

Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study

Pharmaceuticals (Basel, Switzerland), 2024-04, Vol.17 (4), p.519

2024

Volltextzugriff (PDF)

Narrow Histopathological Margins are Acceptable in Surgical Resection of Basal Cell Carcinoma in Japanese: A Single-Center Retrospective Study

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2024-06, Vol.91 (3), p.296-306, Article JNMS.2024_91-308

2024

Volltextzugriff (PDF)

1 – 25 von 408

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(346)
Mit Volltextzugriff
(352)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(235)
Life Sciences & Biomedicine
(221)
Humans
(170)
Male
(100)
Female
(96)
Dermatology
(87)
Biological And Medical Sciences
(68)
Adult
(63)
Middle Aged
(55)
Medical Sciences
(49)
Aged
(42)
Cells, Cultured
(41)
Animals
(31)
Psoriasis
(29)
Keratinocytes - Metabolism
(28)
Atopic Dermatitis
(27)
Keratinocytes - Drug Effects
(25)
Fundamental And Applied Biological Sciences. Psychology
(23)
Immunology
(23)
General & Internal Medicine
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated

Editorial: Special Issue, "Molecular Advances in Skin Diseases 2.0"

Editorial: Special Issue, “Molecular Advances in Skin Diseases”

Nutrition and Psoriasis

The Roles of Sex Hormones in the Course of Atopic Dermatitis

Nutrition and Atopic Dermatitis

The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan

Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan

Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma

Atopic Dermatitis-Like Rash During Evolocumab Treatment of Familial Hypercholesterolemia

The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis

Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study

Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan

Regulatory roles of sex hormones in cutaneous biology and immunology

Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis

Case of alopecia areata during dupilumab treatment for atopic dermatitis

Change in Antinuclear Antibody Titers during Biologic Treatment for Psoriasis

A Case of Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome during Treatment with Brodalumab for Generalized Pustular Psoriasis

Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks

Real‐world blood examination screening data before initiation of biologics for psoriasis patients

Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis

Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis

Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan

Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study

Narrow Histopathological Margins are Acceptable in Surgical Resection of Basal Cell Carcinoma in Japanese: A Single-Center Retrospective Study

Suchergebnisse filtern